Skip to main content
. Author manuscript; available in PMC: 2022 Jan 30.
Published in final edited form as: Psychiatry Res Neuroimaging. 2020 Nov 23;307:111230. doi: 10.1016/j.pscychresns.2020.111230

Table 2.

Sample demographics, substance use and hormone levels

Male (n = 64)
mean (SD)
Female (n = 68)
mean (SD)
Missing data notes
Baseline
Age 14.13 (1.35) 14.55 (1.41)
IQ 110.61 (12.93) 111.26 (9.16)
SES 30.57 (13.32) 29.44 (13.74) Male (n = 1)
FHD 0.33 (0.29) 0.40 (0.31) Male (n = 1)
Lifetime drinks 0.14 (0.48) 0.36 (1.22)
Lifetime marijuana 0.31 (0.91) 0.59 (2.25)
Testosterone (ng/dL) *** 285.53 (178.98) 34.52 (14.45) Male (n = 4), Female (n = 4)
Estradiol (pg/mL) *** 20.46 (9.76) 32.88 (11.94) Male (n = 7), Female (n = 6)a
Follow-up
Age 17.70 (1.93) 18.31 (2.13)
Lifetime drinks 47.91 (62.62) 44.84 (63.20)
Lifetime marijuana 272.04 (439.57) 101.90 (226.32)
Testosterone (ng/dL) *** 401.12 (170.78) 36.08 (12.50) Male (n = 8), Female (n = 9)
Estradiol (pg/mL) ** 35.18 (13.03) 52.61 (42.15) Male (n = 8), Female (n = 9)b
**

p < 0.01;

***

p < 0.001;

a

one additional female adolescent removed for outlying value;

b

four additional female adolescents removed for outlying values